Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...

It’s important to follow guidance on prostate-specific antigen screening that maximizes benefits and minimizes potential harms such as overdiagnosis and overtreatment.

ATLANTA - Each year, millions of American men get a blood test known as a PSA, or prostate-specific antigen, test as part of their yearly checkup. PSA is a protein produced by the prostate gland. If a ...

Dear Dr. Roach: I am a 53-year-old healthy male, and I always request to check my PSA levels each year. My 57-year-old brother's new doctor denied his request for a routine PSA check on their initial ...

A PSA test measures the level of prostate-specific antigen (PSA), a protein that your prostate gland produces, in a sample of your blood. PSA levels can increase due to prostate cancer or other ...

This article was reviewed by Darragh O’Carroll, MD. Prostate-specific antigen (PSA) is a term you’ll probably become familiar with once you start getting screened regularly for prostate cancer ...

An experimental blood test detects prostate cancer so accurately that it may supplant prostate-specific antigen (PSA) levels as a screening tool. Researchers at Johns Hopkins University in Baltimore ...

Biochemical recurrence is when your PSA level starts to rise after finishing prostate cancer treatment, and it may sometimes indicate metastatic disease. Biochemical recurrence is a term for when your ...

DEAR DR. ROACH: I am a 53-year-old healthy male, and I always request to check my PSA levels each year. My 57-year-old brother’s new doctor denied his request for a routine PSA check on their initial ...

NEW YORK (Reuters Health) - The results of a recent study suggest that the initial prostate-specific antigen (PSA) test and rate of change in PSA levels are poor predictors of aggressive prostate ...